ZymoGenetics(美国)

ZymoGenetics

美国ZymoGeneticswww.zymogenetics.comZymoGenetics总部设在西雅图市，其开发的药物包括人造血管凝乳酶Recothrom，主要用于手术时防止失血过多。2010年百时美施贵宝8.85亿美元收购ZymoGenetics Foundedin1981,ZymoGeneticsisabiopharmaceuticalcompanywithadevelopmentpipe lineofproteins,antibodies,andantibody-likemolecules.ZymoGeneticsispubliclytraded(NASDAQ:ZGEN)andheadquarteredinSeattle,WashingtoninthehistoricSeattleCityLightSteamPlantbuilding.Ourmissionistocreatenovelproteindrugsthatwillsignificantlyhelppatientsfighttheirdiseases.Wehavecontributedtothediscoveryordevelopmentofsixrecombinantproteinproductsnowmarketedbyothercompanies.Currentprogramstargetinflammatoryandautoimmunediseases,bleeding,cancerandviralindications.Ourfirstinternallydevelopedproduct,RECOTHROM®Thrombin,topical(Recombinant),wasapprovedbytheU.S.FoodandDrugAdministration(FDA)onJanuary17,2008foruseasatopicalhemostatto